Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.
Insulin as part (rDNA origin) injection Novolog (Novo Nordisk) 28 days Prescribing information Insulin glargine (rDNA origin) vial or cartridge Lantus vial or cartridge (Sanofi-Aventis) 28 days ...
Novolin N vial (Novo Nordisk) 30 days Prescribing information Regular human insulin injection (rDNA origin) Novolin R vial (Novo Nordisk) 30 days Prescribing information Humulin Ultralente human ...
Novo Nordisk lowered the list price on various insulin products, including pre-filled insulin pens and vials. The company suggested that this would mean patients would pay $25-35 for their insulin.